Skip to main content
SpringerLink
Log in
Book cover

Viral Infections of the Human Nervous System pp 65–86Cite as

Progressive Multifocal Leukoencephalopathy

  • Chapter
  • First Online:

  • 1505 Accesses

Part of the book series: Birkhäuser Advances in Infectious Diseases ((BAID))

Abstract

Progressive multifocal leukoencephalopathy (PML) is an opportunistic viral infection of the human central nervous system. It destroys oligodendrocytes leading to neurological deficits associated with demyelination. It most commonly occurs in HIV-infected patients, but increasing numbers of patients are being recognized in the context of immunosuppressive therapies for autoimmune diseases. The precise pathogenesis of infection by JC virus, a human papovavirus remains elusive, but much has been learned since the original description of the pathologic entity PML in 1958. Detection and diagnosis of this disorder has become more sophisticated with MR imaging of the brain and spinal fluid analysis using polymerase chain reaction (PCR) techniques. Immune reconstitution inflammatory syndrome complicates reversal of immunosuppression when PML has established a foothold in the brain. No effective therapy exists, but there is hope for both better management of patients diagnosed with exogenous immunosuppression and future prospects for antiviral therapy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aksamit AJ Jr (1993) Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy. Mayo Clin Proc 68(9):899–910

    PubMed  Google Scholar 

  • Aksamit AJ Jr (1995) Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis. Microsc Res Tech 32(4):302–311. doi:10.1002/jemt.1070320405

    Article  PubMed  Google Scholar 

  • Aksamit AJ (1997) Cerebrospinal fluid in the diagnosis of central nervous system infections. In: Roos KL (ed) Central nervous system infectious diseases and therapy. Marcel Dekker, New York, pp 731–745

    Google Scholar 

  • Aksamit AJ (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 7(4):386–390. doi:10.1080/13550280152537292

    Article  PubMed  CAS  Google Scholar 

  • Aksamit AJ (2006) Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist 12(6):293–298. doi:10.1097/01.nrl.0000250948.04681.96

    Article  PubMed  Google Scholar 

  • Aksamit AJ (2008) Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 10(3):178–185

    Article  PubMed  Google Scholar 

  • Aksamit AJ, Mourrain P, Sever JL, Major EO (1985) Progressive multifocal leukoencephalopathy: investigation of three cases using in situ hybridization with JC virus biotinylated DNA probe. Ann Neurol 18(4):490–496. doi:10.1002/ana.410180412

    Article  PubMed  CAS  Google Scholar 

  • Aksamit AJ, Sever JL, Major EO (1986) Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry. Neurology 36(4):499–504

    Article  PubMed  CAS  Google Scholar 

  • Astrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81(1):93–111

    Article  PubMed  CAS  Google Scholar 

  • Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia-Etxaburu J, Domingo P, Marquez M, Rodriguez-Arrondo FJ, Laguna F, Rubio R, Lacruz Rodrigo J, Mallolas J, de Miguel V (2003) Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 36(8):1047–1052. doi:10.1086/374048

    Article  PubMed  CAS  Google Scholar 

  • Berger JR (2009) Steroids for PML-IRIS: a double-edged sword? Neurology 72(17):1454–1455. doi:10.1212/01.wnl.0000343735.44983.5e

    Article  PubMed  Google Scholar 

  • Berger JR, Houff S (2009) Opportunistic infections and other risks with newer multiple sclerosis therapies. Ann Neurol 65(4):367–377. doi:10.1002/ana.21630

    Article  PubMed  CAS  Google Scholar 

  • Berger JR, Major EO (1999) Progressive multifocal leukoencephalopathy. Semin Neurol 19(2):193–200. doi:10.1055/s-2008-1040837

    Article  PubMed  CAS  Google Scholar 

  • Berger JR, Pall L, Lanska D, Whiteman M (1998) Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4(1):59–68. doi:10.3109/13550289809113482

    Article  PubMed  CAS  Google Scholar 

  • Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, Gerevini S, Bestetti A, Pedale R, Sala S, Lazzarin A, Cinque P (2005) Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 40(5):738–744. doi:10.1086/427698

    Article  PubMed  CAS  Google Scholar 

  • Bozic C, Richman S, Plavina T, Natarajan A, Scanlon J, Subramanyam M, Sandrock A, Bloomgren G (2011) Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. Ann Neurol 70(5):713–721

    Article  Google Scholar 

  • Brooks BR, Walker DL (1984) Progressive multifocal leukoencephalopathy. Neurol Clin 2(2):299–313

    PubMed  CAS  Google Scholar 

  • Calabrese LH, Molloy ES (2008) Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 67(Suppl 3):iii64–65. doi:10.1136/ard.2008.097972

    Article  PubMed  Google Scholar 

  • Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the research on adverse drug events and reports project. Blood 113(20):4834–4840. doi:10.1182/blood-2008-10-186999

    Article  PubMed  CAS  Google Scholar 

  • Castaigne P, Rondot P, Escourolle R, Ribadeau dumas J, Cathala F, Hauw J (1974) Progressive multifocal leukoencephalopathy and multiple gliomas. Rev Neurol 130(9–10):379–392

    PubMed  CAS  Google Scholar 

  • Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52(3):623–625

    Article  PubMed  CAS  Google Scholar 

  • Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9(4):438–446. doi:10.1016/S1474-4422(10)70028-4

    Article  PubMed  CAS  Google Scholar 

  • Clifford D, Nath A, Cinque P, Brew BJ, Workman A, Gorelik L, Zhao J, Duda P (2011a) Mefloquine treatment in patients with progressive multifocal leukoencephalopathy. Neurology 9(4 Suppl):A28

    Google Scholar 

  • Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL (2011b) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68(9):1156–1164. doi:10.1001/archneurol.2011.103

    Article  PubMed  Google Scholar 

  • De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, Alba L, Murri R, Ippolito G, Cauda R, Monforte A, Antinori A (2001) Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study. J Neurovirol 7(4):364–368

    Article  PubMed  Google Scholar 

  • De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, Marra CM, Antinori A (2008) Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 22(14):1759–1767. doi:10.1097/QAD.0b013e32830a5043

    Article  PubMed  Google Scholar 

  • Del Valle L, Azizi SA, Krynska B, Enam S, Croul SE, Khalili K (2000) Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme. Ann Neurol 48(6):932–936

    Article  PubMed  Google Scholar 

  • Du Pasquier RA, Koralnik IJ (2003) Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol 9(Suppl 1):25–31. doi:10.1080/13550280390195315

    PubMed  Google Scholar 

  • Du Pasquier RA, Corey S, Margolin DH, Williams K, Pfister LA, De Girolami U, Mac Key JJ, Wuthrich C, Joseph JT, Koralnik IJ (2003) Productive infection of cerebellar granule cell neurons by JC virus in an HIV + individual. Neurology 61(6):775–782

    Article  PubMed  Google Scholar 

  • Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306(5700):1380–1383. doi:10.1126/science.1103492

    Article  PubMed  CAS  Google Scholar 

  • Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB (1995) Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33(2):484–486

    PubMed  CAS  Google Scholar 

  • Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51(2):458–469

    PubMed  CAS  Google Scholar 

  • Gallia GL, Houff SA, Major EO, Khalili K (1997) Review: JC virus infection of lymphocytes—revisited. J Infect Dis 176(6):1603–1609

    Article  PubMed  CAS  Google Scholar 

  • Geschwind MD, Skolasky RI, Royal WS, McArthur JC (2001) The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J Neurovirol 7(4):353–357. doi:10.1080/13550280152537238

    Article  PubMed  CAS  Google Scholar 

  • Gibson PE, Knowles WA, Hand JF, Brown DW (1993) Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 39(4):278–281

    Article  PubMed  CAS  Google Scholar 

  • Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E, Millar L, Timpone J (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338(19):1345–1351. doi:10.1056/NEJM199805073381903

    Article  PubMed  CAS  Google Scholar 

  • Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W (1988) Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318(5):301–305. doi:10.1056/NEJM198802043180507

    Article  PubMed  CAS  Google Scholar 

  • Houston S, Roberts N, Mashinter L (2001) Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus. Clin Infect Dis 32(1):150–152. doi:10.1086/317539

    Article  PubMed  CAS  Google Scholar 

  • Kast RE, Focosi D, Petrini M, Altschuler EL (2007) Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone. Bone Marrow Transplant 39(12):811–812. doi:10.1038/sj.bmt.1705682

    Article  PubMed  CAS  Google Scholar 

  • Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353(4):369–374. doi:10.1056/NEJMoa051782

    Article  PubMed  CAS  Google Scholar 

  • Koralnik IJ (2006) Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 60(2):162–173. doi:10.1002/ana.20933

    Article  PubMed  Google Scholar 

  • Korman BD, Tyler KL, Korman NJ (2009) Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol 145(8):937–942. doi:10.1001/archdermatol.2009.175

    Article  PubMed  Google Scholar 

  • Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353(4):375–381. doi:10.1056/NEJMoa051847

    Article  PubMed  CAS  Google Scholar 

  • Liu CK, Wei G, Atwood WJ (1998) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2–6)-linked sialic acids. J Virol 72(6):4643–4649

    PubMed  CAS  Google Scholar 

  • Major EO (2000) From telomeres to T-antigens: many roads…multiple pathways…novel associations in the search for the origins of human gliomas. Ann Neurol 48(6):823–825

    Article  PubMed  CAS  Google Scholar 

  • Major EO, Amemiya K, Elder G, Houff SA (1990) Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 27(4):461–471. doi:10.1002/jnr.490270405

    Article  PubMed  CAS  Google Scholar 

  • Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5(1):49–73

    PubMed  CAS  Google Scholar 

  • Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, Ruiz A, Bowen BC, Huang ML, Queen-Baker J, Andersen J, Kelly S, Shriver S (2002) A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16(13):1791–1797

    Article  PubMed  CAS  Google Scholar 

  • Mateen FJ, Muralidharan R, Carone M, van de Beek D, Harrison DM, Aksamit AJ, Gould MS, Clifford DB, Nath A (2011) Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 70(2):305–322. doi:10.1002/ana.22408

    Article  PubMed  Google Scholar 

  • McGuire D, Barhite S, Hollander H, Miles M (1995) JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 37(3):395–399. doi:10.1002/ana.410370316

    Article  PubMed  CAS  Google Scholar 

  • Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O’Connor PW (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348(1):15–23. doi:10.1056/NEJMoa020696

    Article  PubMed  CAS  Google Scholar 

  • Nath A, Venkataramana A, Reich DS, Cortese I, Major EO (2006) Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology 66(1):149–150. doi:10.1212/01.wnl.0000191322.93310.a1

    Article  PubMed  CAS  Google Scholar 

  • Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A (2007) Progressive multifocal leucoencephalopathy in a patient with sarcoidosis–successful treatment with cidofovir and mirtazapine. Rheumatology 46(5):888–890. doi:10.1093/rheumatology/kem049

    Article  PubMed  CAS  Google Scholar 

  • Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1(7712):1257–1260

    Article  PubMed  CAS  Google Scholar 

  • Rahmlow M, Shuster EA, Dominik J, Deen HG Jr, Dickson DW, Aksamit AJ Jr, Robles HA, Freeman WD (2008) Leflunomide-associated progressive multifocal leukoencephalopathy. Arch Neurol 65(11):1538–1539. doi:10.1001/archneur.65.11.1538

    Article  PubMed  Google Scholar 

  • Razonable RR, Aksamit AJ, Wright AJ, Wilson JW (2001) Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 76(11):1171–1175

    Article  PubMed  CAS  Google Scholar 

  • Rice GP, Hartung HP, Calabresi PA (2005) Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64(8):1336–1342. doi:10.1212/01.WNL.0000158329.30470.D0

    Article  PubMed  CAS  Google Scholar 

  • Richardson EP Jr (1961) Progressive multifocal leukoencephalopathy. N Engl J Med 265:815–823. doi:10.1056/NEJM196110262651701

    Article  PubMed  Google Scholar 

  • Royal W 3rd, Dupont B, McGuire D, Chang L, Goodkin K, Ernst T, Post MJ, Fish D, Pailloux G, Poncelet H, Concha M, Apuzzo L, Singer E (2003) Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 9(3):411–419. doi:10.1080/13550280390201740

    Article  PubMed  CAS  Google Scholar 

  • Rudick R, Stuart W, Calabresi P, et al. (2006) Natalizumab plus Interferon Beta-1a for relapsing multiple sclerosis. New England Journal of Medicine 354:911–923

    Google Scholar 

  • Ryschkewitsch CF, Jensen PN, Monaco MC, Major EO (2010) JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 68(3):384–391. doi:10.1002/ana.22137

    Article  PubMed  Google Scholar 

  • Tan K, Roda R, Ostrow L, McArthur J, Nath A (2009) PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72(17):1458–1464. doi:10.1212/01.wnl.0000343510.08643.74

    Article  PubMed  CAS  Google Scholar 

  • Telenti A, Marshall WF, Aksamit AJ, Smilack JD, Smith TF (1992) Detection of JC virus by polymerase chain reaction in cerebrospinal fluid from two patients with progressive multifocal leukoencephalopathy. Eur J Clin Microbiol Infect Dis 11(3):253–254

    Article  PubMed  CAS  Google Scholar 

  • Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N Engl J Med 353(4):362–368. doi:10.1056/NEJMoa051586

    Article  PubMed  Google Scholar 

  • Viallard JF, Lazaro E, Ellie E, Eimer S, Camou F, Caubet O, Lafon ME, Fleury H, Pellegrin JL (2007) Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis. Infection 35(1):33–36. doi:10.1007/s15010-006-5103-y

    Article  PubMed  CAS  Google Scholar 

  • Vollmer-Haase J, Young P, Ringelstein EB (1997) Efficacy of camptothecin in progressive multifocal leucoencephalopathy. Lancet 349(9062):1366. doi:10.1016/S0140-6736(05)63201-1

    Article  PubMed  CAS  Google Scholar 

  • von Einsiedel RW, Fife TD, Aksamit AJ, Cornford ME, Secor DL, Tomiyasu U, Itabashi HH, Vinters HV (1993) Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 240(7):391–406

    Article  Google Scholar 

  • Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, Bogousslavsky J, Picard F, Landis T, Du Pasquier RA (2006) Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 77(9):1079–1082. doi:10.1136/jnnp.2006.092353

    Article  PubMed  CAS  Google Scholar 

  • Walker D, Frisque R (1986) The biology and molecular biology of JC virus. In: Salzman NP (ed) The Papovaviridae. Plenum, New York

    Google Scholar 

  • Weber T, Major EO (1997) Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology 40(2–3):98–111

    Article  PubMed  CAS  Google Scholar 

  • Weber T, Turner RW, Frye S, Luke W, Kretzschmar HA, Luer W, Hunsmann G (1994) Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 8(1):49–57

    Article  PubMed  Google Scholar 

  • Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinstein LJ, Preziosi TJ, Conley FK (1972) Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 286(8):385–390. doi:10.1056/NEJM197202242860801

    Article  PubMed  CAS  Google Scholar 

  • Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP (1993) Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187(1):233–240

    PubMed  CAS  Google Scholar 

  • Zurhein G, Chou SM (1965) Particles resembling papova viruses in human cerebral demyelinating disease. Science 148(3676):1477–1479

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo College of Medicine, Mayo clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Allen J. Aksamit

Authors
  1. Allen J. Aksamit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allen J. Aksamit .

Editor information

Editors and Affiliations

  1. , Health Sciences Centre, University of Manitoba, Sherbrook Street 820, Winnipeg, R3A 1R9, Manitoba, Canada

    Alan C. Jackson

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Basel

About this chapter

Cite this chapter

Aksamit, A.J. (2013). Progressive Multifocal Leukoencephalopathy. In: Jackson, A. (eds) Viral Infections of the Human Nervous System. Birkhäuser Advances in Infectious Diseases. Springer, Basel. https://doi.org/10.1007/978-3-0348-0425-7_4

Download citation

Publish with us

Policies and ethics

Search

Navigation